ASC09/ritonavir group
ASC09F-CTP-ZY-01
Unknown small_molecule terminated
Quick answer
ASC09/ritonavir group for 2019-nCoV is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- 2019-nCoV
- Phase
- Unknown
- Modality
- small_molecule
- Status
- terminated